University of Texas/MD Anderson Cancer Center Dept of MD Anderson (18) is a clinical research site located in Houston, Texas, United States 77030-4009.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
University of Texas/MD Anderson Cancer Center Dept of MD Anderson (18) has participated in 1 clinical trials.
Therapeutic areas: Diffuse Large B-cell Lymphoma.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Texas/MD Anderson Cancer Center Dept of MD Anderson (18) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Texas/MD Anderson Cancer Center Dept of MD Anderson (18) has 1 clinical trials on record. Their work covers Diffuse Large B-cell Lymphoma.
University of Texas/MD Anderson Cancer Center Dept of MD Anderson (18) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.